NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cytogel Pharma

Cytogel Pharma

Private
Darien, ConnecticutHealthcare & Life Scienceshttps://cytogelpharma.com/

Last Round

VC Round

Apr 29, 2026

Total Funding Raised

$1.8M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Cytogel Pharma is a clinical-stage biopharmaceutical company that develops first-in-class drug candidates from the novel endomorphin family of molecules to target key pain pathways and alleviate pain.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalnon-addictive pain reliefdrug developmentclinical-stage biotechendomorphinanalgesicpain managementopioid alternativedrug licensingclinical trialsbiotech startupcentral nervous systemCNSdrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cytogel Pharma Comparables

Compare Cytogel Pharma with similar companies based on industry and business-model similarity.

Cytogel Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Latigo Biotherapeutics
83%
Neumentum, Inc.
81%
Tafalgie Therapeutics
80%

Cytogel Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 29, 2026
Early Stage VCMar 26, 2026
Early FundingNov 20, 2025
DebtOct 14, 2025
VC RoundJun 10, 2023
Debt
Jun 15, 2022

Key People

Founding team and executive leadership

C. Dean Maglaris

CEO

Executive Team

Cytogel Pharma Investors

Notable investors and investment history

Cytogel Pharma investors
InvestorRounds
Centripetal Capital PartnersVC Round
U.S. GovernmentGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors increased 46% MoM.

  • Nov 20, 2025

    Completed an early funding round.

Cytogel Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cytogel Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cytogel Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersDarien, Connecticut
Employee Range9
Year Founded2002
Last FundingApr 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.